Lack of effect of topical finasteride suggests an endocrine role for dihydrotestosterone.
T M
TM
Price
S
S
Allen
G V
GV
Pegram
D000287:Administration, Topical; D042944:Cholestenone 5 alpha-Reductase; D013196:Dihydrotestosterone / Q000097:blood*; D004305:Dose-Response Relationship, Drug; D004703:Endocrine System / Q000502:physiology; D004791:Enzyme Inhibitors / Q000008:administration & dosage*; D005260:Female; D018120:Finasteride / Q000008:administration & dosage*; D006628:Hirsutism / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D010088:Oxidoreductases / Q000037:antagonists & inhibitors / Q000378:metabolism; D013739:Testosterone / Q000097:blood; D017211:Treatment Failure
D004791:Enzyme Inhibitors; D013196:Dihydrotestosterone; D013739:Testosterone; D018120:Finasteride; D010088:Oxidoreductases; D042944:Cholestenone 5 alpha-Reductase